Thursday, 16 August 2012

Drug reporting positive results for MS temporarily withdrawn from market

Photo: Makers of the cancer drug, alemtuzumab, which has been shown to benefit people with relapsing-remitting MS have reported they are applying for a licence for the medicine to be available to treat people with MS.


http://www.mssociety.org.uk/ms-news/2012/08/drug-reporting-positive-results-ms-temporarily-withdrawn-market
Source MS Society:

Makers of the cancer drug, alemtuzumab, which has been shown to benefit people with relapsing-remitting MS have reported they are applying for a licence for the medicine to be available to treat people with MS.

For more information click here.